Estrogen receptor aα enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Cao, Peng ^a   Feng, Fan ^a   Dong, Guofu ^b   Yu, Chunyong ^a   Feng, Sizhe ^a   Song, Erlin ^c,d   Shi, Guobing ^a   Liang, Yong ^a   Liang, Guobiao ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c General Hospital of the Chinese PLA Beijing Region   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; TRANSCRIPTION FACTOR ETS 1; ESTROGEN RECEPTOR ALPHA, HUMAN; LIGAND;

ARTICLE; BIOACCUMULATION; CELL FRACTIONATION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; NEUROBLASTOMA CELL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CARCINOGENESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEUROBLASTOMA; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR INVASION;

CARCINOGENESIS; CELL MOVEMENT; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; NEOPLASM INVASIVENESS; NEUROBLASTOMA; PROTEIN INTERACTION MAPS; PROTO-ONCOGENE PROTEIN C-ETS-1; TRANSCRIPTIONAL ACTIVATION;

EID: 84934271365     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1495-3     Document Type: Article

References (38)

1. Cowley SM, Hoare S, Mosselman S, Parker MG. Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem. 1997;272:19858-62.
2. Chai J, Lee KF, Ng EH, Yeung WS, Ho PC. Ovarian stimulation modulates steroid receptor expression and spheroid attachment in peri-implantation endometria: studies on natural and stimulated cycles. Fertil Steril. 2011;96:764-8.
3. Ding L, Niu C, Zheng Y, Xiong Z, Liu Y, Lin J, et al. FHL1 interacts with oestrogen receptors and regulates breast cancer cell growth. J Cell Mol Med. 2011;15:72-85.
4. Egloff AM, Rothstein ME, Seethala R, Siegfried JM, Grandis JR, Stabile LP. Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma. Clin Cancer Res. 2009;15:6529-40.
5. Lovén J, Zinin N, Wahlström T, Müller I, Brodin P, Fredlund E, et al. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc Natl Acad Sci U S A. 2010;107:1553-8.
6. Garcia-Segura LM, Sanz A, Mendez P. Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology. 2006;84:275-9.
7. Alipov G, Nakayama T, Ito M, Kawai K, Naito S, Nakashima M, et al. Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology. 2005;46:202-8.
8. Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, et al. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer. Clin Cancer Res. 2005;11:2111-22.
9. Kalet BT, Anglin SR, Handschy A, O'Donoghue LE, Halsey C, Chubb L, et al. Transcription factor Ets1 cooperates with estrogen receptor aα to stimulate estradiol-dependent growth in breast cancer cells and tumors. PLoS One. 2013;8:e68815.
10. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, et al. Modulation of oestrogen receptor signaling by association with the activated dioxin receptor. Nature. 2003;423:545-50.
11. Beischlag TV, Perdew GH. ER a-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription. J Biol Chem. 2005;280:21607-11.
12. Mizumoto H, Saito T, Ashihara K, Nishimura M, Tanaka R, Kudo R. Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-alpha gene in endometrial carcinoma cells. Int J Cancer. 2002;100:401-6.
13. Zhu M, Li M, Zhang F, Feng F, Chen W, Yang Y, et al. FBI-1 enhances ETS-1 signaling activity and promotes proliferation of human colorectal carcinoma cells. PLoS One. 2014;9:e98041.
14. Cui J, Yang Y, Zhang C, Hu P, Kan W, Bai X, et al. FBI-1 functions as a novel AR co-repressor in prostate cancer cells. Cell Mol Life Sci. 2011;68:1091-103.
15. Yang Q, Feng F, Zhang F, Wang CP, Lu YY, Gao XD, et al. LINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cell. Cell Signal. 2013;25:2652-60.
16. Zhang F, Feng F, Yang PX, Li ZJ, You JH, Xie W, et al. Four-and-a-half-LIM protein 1 down-regulates estrogen receptor aα activity through repression of AKT phosphorylation in human breast cancer cell. Int J Biochem Cell Biol. 2012;44:320-6.
17. Song E, Ma X, Li H, Zhang P, Ni D, Chen W, et al. Attenuation of krüppel-like factor 4 facilitates carcinogenesis by inducing g1/s phase arrest in clear cell renal cell carcinoma. PLoS One. 2013;8:e67758.
18. Zhang P, Ma X, Song E, Chen W, Pang H, Ni D, et al. Tubulin cofactor A functions as a novel positive regulator of ccRCC progression, invasion and metastasis. Int J Cancer. 2013;133:2801-11.
19. Lu Y, Feng F, Yang Y, Gao X, Cui J, Zhang C, et al. LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells. Cell Signal. 2013;25:479-89.
20. Cui L, Li M, Feng F, Yang Y, Hang X, Cui J, et al. MEIS1 functions as a potential AR negative regulator. Exp Cell Res. 2014;328:58-68.
21. Cui JJ, Meng XF, Gao XD, Tang G. Curcumin decreases the expression of Pokemon by suppressing the binding activity of the Sp1 protein in human lung cancer cells. Mol Biol Rep. 2010;37:1627-32.
22. Qin X, Wang XH, Yang ZH, Ding LH, Xu XJ, Cheng L, et al. Repression of NFAT3 transcriptional activity by estrogen receptors. Cell Mol Life Sci. 2008;65:2752-62.
23. Feng F, Lu YY, Zhang F, Gao XD, Zhang CF, Meredith A, et al. Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma. World J Gastroenterol. 2013;19:1068-78.
24. Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cell Signal. 2006;18:2262-71.
25. Span PN, Manders P, Heuvel JJ, Thomas CM, Bosch RR, Beex LV, et al. Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer. Oncogene. 2002;21:8506-9.
26. Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, et al. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol. 1996;16:538-47.
27. Wasylyk C, Bradford AP, Gutierrez-Hartmann A, Wasylyk B. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene. 1997;14:899-913.
28. Lee SK, Kim HJ, Na SY, Kim TS, Choi HS, Im SY, et al. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem. 1998;273:16651-64.
29. Lee SK, Kim HJ, Kim JW, Lee JW. Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53. Mol Endocrinol. 1999;13:1924-33.
30. Klinge CM. Estrogen receptor interaction with coactivators and co-repressors. Steroids. 2000;65:227-51.
31. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81:1269-304.
32. Dobrzycka KM, Townson SM, Jiang S, Oesterreich S. Estrogen receptor corepressors - a role in human breast cancer? Endocr Relat Cancer. 2003;10:517-36.
33. Wang X, Yang Z, Zhang H, Ding L, Li X, Zhu C, et al. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT. Biochim Biophys Acta. 1783;2008:1220-8.
34. Cheng L, Li J, Han Y, Lin J, Niu C, Zhou Z, et al. PES1 promotes breast cancer by differentially regulating ERaα and ERβ. J Clin Invest. 2012;122:2857-70.
35. Lu G, Zhang Q, Huang Y, Song J, Tomaino R, Ehrenberger T, et al. Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor. Cancer Cell. 2014;26:222-2234.
36. Feng FY, Brenner JC, Hussain M, Chinnaiyan AM. Molecular pathways: targeting ETS gene fusions in cancer. Clin Cancer Res. 2014;20:4442-8.
37. Hui AM, Zhang W, Chen W, Xi D, Purow B, Friedman GC, et al. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Cancer Res. 2004;64:9115-23.
38. Jiang K, Yang Z, Cheng L, Wang S, Ning K, Zhou L, et al. Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2. J Biol Chem. 2013;288:24590-9.